HSA & FSA accepted; best-value for top quality care
Same-day mental health, weight loss, and primary care appointments available
Now accepting insuranceHSA & FSA accepted; best-value for top quality careSame-day mental health, weight loss, and primary care appointments availableNow accepting insuranceRetatrutide is an investigational medication currently being studied for chronic weight management in adults with obesity or overweight, along with at least one weight-related condition such as hypertension or type 2 diabetes. It is not yet FDA-approved and is available only through clinical trials.
Looking for retatrutide prescription online? You can speak with a licensed provider on Klarity Health to learn more about clinical trial eligibility or to discuss alternative treatment options, if medically appropriate.
Providers on Klarity Health are independent practitioners with clinical autonomy; a diagnosis, treatment, or prescription is not guaranteed.
Providers on Klarity Health are independent practitioners with clinical autonomy; a diagnosis, treatment, or prescription is not guaranteed.
You’re unique. And your needs are too. You deserve weight loss treatment from a provider committed to you. That’s why you can find a weight loss specialist on Klarity Health and access:
From an experienced, board-certified healthcare professional.
or in-person through treatment tailored to you**
Your information is private, secure, and 100% HIPAA compliant.
*Your provider will discuss treatment options with you, which may or may not include medication.
Klarity Health connects you with experienced, licensed providers who specialize in the treatment of weight loss. Select your state to see available providers.
To learn whether retatrutide is an option for you:
Retatrutide is not yet approved, but early trial data suggest it may offer greater weight loss than other medications in its class. Here’s how it compares based on available information:
| Medication | Receptor Targeting | Weight Loss (avg.) | Status |
| Retatrutide | GLP-1, GIP, Glucagon | ~24% in 48 weeks | In clinical trials |
| Tirzepatide | GLP-1, GIP | ~21% in 72 weeks | FDA-approved |
| Semaglutide | GLP-1 only | ~15% in 68 weeks | FDA-approved |
These comparisons are based on clinical trials with different durations and populations. A healthcare provider can help you decide which treatment is best for your needs.
Read through stories from real patients who received treatment from healthcare providers on Klarity.
*Appointments are generally available within 24 hours. Free initial consultations are available only with select providers. Prescriptions, particularly for controlled substances, may require an in-person evaluation depending on the state of residence and current federal regulations.
The information provided in this article is for educational purposes only and should not be construed as medical advice. Always seek the guidance of a qualified healthcare professional with any questions or concerns you have regarding your health. Providers on Klarity Health are independent practitioners with clinical autonomy. Nothing in this article is intended to diagnose or treat any condition, including guaranteeing prescription medication of any kind or dosage. Not all providers on Klarity Health prescribe all medications, particularly medications that are controlled substances.